Sacyl Pharmaceuticals
Biotechnology Research • 
New York Metropolitan Area, United States • 1-10 Employees
Company overview
| Headquarters | New York Metropolitan Area, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 1-10 |
Key Contacts at Sacyl Pharmaceuticals
Gregory S Kopf
Co-Founder, Chief Scientific Officer
Steve Kretschmer
Chief Executive Officer
Clemens Steegborn
Co-Founder, Board Of Directors
Sacyl Pharmaceuticals Email Formats
Sacyl Pharmaceuticals uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@sacylpharma.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@sacylpharma.com | 100% |
About Sacyl Pharmaceuticals
Sacyl Pharmaceuticals aims to exploit potent soluble adenylyl cyclase (sAC) inhibition for the development of first-in-class oral, non-hormonal, on demand contraceptives for men and women.
Sacyl Pharmaceuticals revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Sacyl Pharmaceuticals has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Sacyl Pharmaceuticals has never raised funding before.
Sacyl Pharmaceuticals Tech Stack
Discover the technologies and tools that power Sacyl Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
JavaScript libraries
United KingdomFrequently asked questions
4.8
40,000 users
